[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557059":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":22,"responsibleParty":42,"collaborators":44,"id":48,"slug":7,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":70,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","Enhanced Diffusion Software","Application of specific sequences with the use of Enhanced Diffusion Software during Patient MRI",[14],{"name":15,"affiliation":5,"role":16},"Evis Sala","PRINCIPAL_INVESTIGATOR",[18],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","+390630158637","evis.sala@policlinicogemelli.it",[23,34],{"facility":24,"status":7,"city":25,"state":7,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":7},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Radiologia","Roma","00168","Italy",{"type":29,"coordinates":30},"Point",[31,32],11.10642,44.99364,{"lat":32,"lon":31},{"facility":35,"status":7,"city":36,"state":7,"zip":26,"country":27,"cosmosGeoPoint":37,"geoPoint":41,"contacts":7},"Advanced Radiology Center","Rome",{"type":29,"coordinates":38},[39,40],12.51133,41.89193,{"lat":40,"lon":39},{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[45],{"name":46,"class":47},"GE Healthcare","INDUSTRY","100557059",false,"NCT06533189","Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study","Developing a Whole-body Magnetic Resonance Imaging and Diffusion-weighted Imaging State-of-the-art Protocol, a Pilot Study","WANDA","Inclusion Criteria:\n\n* Age ≥18 years old;\n* Patients with diagnosis of multiple myeloma, lymphoma, lung, prostate, breast, colorectal and gynecologic cancers;\n* Patients with genetic syndromes responsible for an increased predisposition to neoplasms (e.g. Li Fraumeni syndrome);\n* Signed written informed consent to personal data treatment for research purposes\n\nExclusion Criteria:\n\n* Age \\\u003C18 years old;\n* Refusal to sign the written informed consent to personal data treatment for research purposes.","ALL","18 Years",{"count":58,"type":59},120,"ESTIMATED","OBSERVATIONAL","Whole-body magnetic resonance imaging (WB-MRI) is a non-ionizing imaging method that can provide WB coverage using essential imaging contrasts with the possibility to include sequences focusing in specific body-regions as needed per case. WB-MRI is increasingly being used for the management of cancer patients, especially metastatic ones. An integral part of WB-MRI is becoming whole-body diffusion-weighted MRI (WB-DWI) which is a non-invasive tool used for staging and response evaluation in oncologic practice. WB-DWI is an inherently noisy technique, resulting in it accounting for more than 50% of the acquisition time of conventional whole-body MRI studies with overall duration at least 1-hour. Reducing acquisition times, without compromising image or diagnostic quality would facilitate the wider adoption of clinical WBDWI, reducing costs, and improving the patient experience",[63,64,65],"Whole Body Imaging","Cancer","Genetic Predisposition",[67,68,69],"MRI","Whole Body MRI","Genetic Predisposition to Cancer","NOT_YET_RECRUITING","2024-07-30",{"date":73,"type":74},"2024-08-01","ACTUAL",{"date":76,"type":59},"2024-09-01",{"date":78,"type":59},"2026-02-28",{"name":5,"class":6},2]